Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

198.47 +3.95 (+2.03%)

Streaming Delayed Price Updated: 2:41 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday? ↗

February 29, 2024

Wall Street exhaled a sigh of relief as the Federal Reserve’s favored gauge of inflation cooled as anticipated in January, quelling fears that an unexpected rise in the Consumer Price Index (CPI) might...

Via Benzinga

Topics Economy

Natera to Participate in March Investor Conferences

February 29, 2024

From Natera, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 28, 2024

Via Benzinga

Recap: Natera Q4 Earnings ↗

February 28, 2024

Via Benzinga

Earnings Preview For Natera ↗

February 27, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Natera Through 9 Analysts ↗

February 20, 2024

Via Benzinga

Natera Reports Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024

From Natera, Inc.

Via Business Wire

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

There are signs that NASDAQ:NTRA may be ready to breakout. ↗

February 16, 2024

NATERA INC (NASDAQ:NTRA) has a good technical rating of 10 out of 10 and could possibly break out.

Via Chartmill

Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold ↗

February 27, 2024

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.

Via Benzinga

Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests

February 27, 2024

From Natera, Inc.

Via Business Wire

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer

February 26, 2024

From Natera, Inc.

Via Business Wire

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call

February 20, 2024

From Natera, Inc.

Via Business Wire

Expert Ratings For Natera ↗

January 17, 2024

Via Benzinga

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗

February 06, 2024

These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.

Via InvestorPlace

NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy ↗

February 06, 2024

NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending.

Via InvestorPlace

Topics Bankruptcy

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy ↗

February 05, 2024

Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures.

Via Benzinga

Topics Bankruptcy

Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling ↗

February 05, 2024

The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

New Study Validates Signatera™ in Endometrial Cancer

February 05, 2024

From Natera, Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

New Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer

January 30, 2024

From Natera, Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

Jury Rules in Favor of Natera in Patent Infringement Lawsuit Against CareDx; Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties

January 29, 2024

From Natera, Inc.

Via Business Wire

Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies

January 25, 2024

From Natera, Inc.

Via Business Wire

Natera Acquires Reproductive Health Assets from Invitae

January 22, 2024

From Natera, Inc.

Via Business Wire

Natera to Present New Data from the CIRCULATE-Japan and BESPOKE CRC Studies at ASCO GI 2024 Supporting Signatera’s Clinical Utility in CRC

January 18, 2024

From Natera, Inc.

Via Business Wire

Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle ↗

January 17, 2024

The company must pay $57 million in damages, but that's far less than expected.

Via Investor's Business Daily

Topics Intellectual Property

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket ↗

January 17, 2024

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market...

Via Benzinga

Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

January 17, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday. Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as...

Via Benzinga

Topics Stocks

Natera Provides Update on Ravgen Trial

January 16, 2024

From Natera, Inc.

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.